You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Hensley Mark Earl · SEC Form 4 · Filed Aug 3, 2026
Exercise
Reported value range
Not reported
Hensley Mark Earl Chief Operating Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jul 31, 2026
Public filing date
Aug 3, 2026
Filing lag
Filed 3 days later
HRTX daily price context
Close on/before transaction
$0.5
Jul 31, 2026
First close after public filing
$0.51
Aug 3, 2026
30-day return after filing
-38.82%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,769 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-329848
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /De/ HRTX Current | Exercise | Jul 31, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 31, 2026 | $0 |